Sign in

CIK 0001439725

  • Non-accelerated filer
  • Smaller reporting company

BIODESIX INC

Sign in to watch
Ticker
BDSX
Exchange
Nasdaq
Industry
Services-Medical Laboratories
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
203986492
Phone
+1 303-417-0500
Business address
919 WEST DILLON ROAD, LOUISVILLE, CO, 80027
  1. 4 Derivatives Options or other derivatives
  2. 4/A Open-market buy Director bought 2,298,850 shares at $4.35 ($9,999,998)
  3. 4 Exercise or conversion CFO, Sec'y & Treasurer acquired 5,679 shares (option exercise)
  4. 4 Open-market buy Director bought 2,298,850 shares at $4.35 ($9,999,998)
  5. 4 Open-market buy Director bought 147,800 shares at $4.35 ($642,930)
  6. 4 Open-market buy Director bought 160,919 shares at $4.35 ($699,998)
  7. 4 Open-market buy Director bought 5,855 shares at $4.29 ($25,132)
  8. 4 Derivatives Options or other derivatives
  9. 3 Insider Initial Statement of Ownership
  10. 4 Open-market buy Director bought 10,000 shares at $6.18 ($61,753)
  11. 4 Open-market buy Director bought 20,000 shares at $6.34 ($126,756)
  12. 4 Open-market buy Director bought 60,000 shares at $6.50 ($390,186)
  13. 4 Open-market buy Director bought 9,497 shares at $6.34 ($60,220)
  14. 4 Open-market buy Director bought 28,361 shares at $6.33 ($179,502)
  15. 4 Open-market buy Director bought 20,000 shares at $6.51 ($130,104)
  16. 4 Open-market buy President & CEO bought 3,000 shares at $6.46 ($19,375)
  17. 4 Open-market buy CFO, Sec'y & Treasurer bought 1,000 shares at $6.51 ($6,510)
  18. 4 Open-market buy Director bought 8,396 shares at $8.04 ($67,490)
  19. 4 Open-market buy Director bought 50,000 shares at $7.69 ($384,440)
  20. 4 Open-market buy Director bought 1,604 shares at $7.12 ($11,416)

Page 15 of 17 · 336 filings